Artificial Intelligence In Life Sciences Market Forecast To Reach $10.43 Billion By 2030: Key Trends Explained
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Artificial Intelligence In Life Sciences Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The artificial intelligence in life sciences market size has witnessed substantial expansion in recent years. Projections indicate it will progress from $3.59 billion in 2025 to achieve $4.44 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.6%. The historical surge can be attributed to several factors including the rising complexity of biological datasets, the broadening of genomics research, increased adoption of digital lab technologies, the early integration of AI into biotechnology research, and the growing need for accelerated research cycles.
The artificial intelligence in life sciences market size is anticipated to undergo significant expansion over the next few years. It is projected to climb to $10.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 23.8%. This growth during the forecast period can be attributed to heightened investments in personalized medicine, the increasing deployment of AI-enabled laboratory automation, the expansion of cloud-based platforms for life sciences, growing collaborations between technology and life science firms, and increasing regulatory approval of AI-driven insights. Noteworthy trends for the forecast period include the expanding integration of AI across various life science workflows, a rising adoption of AI-driven data analytics platforms, a greater utilization of automation in laboratory operations, the growth of AI-based precision medicine applications, and an intensified focus on accelerating research outcomes.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence In Life Sciences Market Development Factors: What’s Supporting Demand?
Growing fascination with real-time remote patient monitoring (RPM) systems is anticipated to drive the expansion of artificial intelligence in the life sciences market moving ahead. A remote patient monitoring system represents a technologically advanced healthcare solution developed to observe individuals’ well-being beyond conventional medical environments. Artificial intelligence in life sciences plays a crucial role in remote patient monitoring, offering ongoing, tailored, and data-informed insights that facilitate proactive health management. As an illustration, in April 2025, the Peterson Center on Healthcare, a US-based non-profit organization, documented that expenditures for remote therapeutic monitoring (RTM) within Traditional Medicare escalated from $2.2 million in 2022 to $10.4 million in 2023. Additionally, during 2023, 451,000 patients enrolled in Traditional Medicare utilized RPM services. Consequently, the rising adoption of real-time remote patient monitoring (RPM) systems is fueling the expansion of artificial intelligence in the life sciences market.
Artificial Intelligence In Life Sciences Market Segment Landscape: Which Areas Lead Development?
The artificial intelligence in life sciences market covered in this report is segmented –
1) By Offering: Software, Hardware, Services
2) By Deployment: On-Premises, Cloud-Based
3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision And Personalized Medicine, Patient Monitoring
Subsegments:
1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)
2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies
3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services
Artificial Intelligence In Life Sciences Market Transformation Trends: What Innovations Are Driving Change?
Companies operating in the artificial intelligence in the life sciences market are concentrating on innovative products featuring technological advancements, such as drug discovery software, to sustain their market position. Drug discovery software denotes a range of computer programs and applications developed to assist pharmaceutical and biotechnology researchers with the process of finding new drugs. For instance, in December 2023, Merck, a Germany-based science and technology company, introduced AIDDISON, a revolutionary drug discovery software. This software, the first of its kind, integrates virtual molecule design with real-world manufacturability, utilizing generative AI, machine learning, and computer-aided drug design. AIDDISON effectively identifies drug candidates from numerous possibilities, considering essential properties like non-toxicity and solubility. Its capability to connect virtual molecule design with real-world manufacturability stands out as a significant application of artificial intelligence in the life sciences sector.
Artificial Intelligence In Life Sciences Market Industry Leaders And Competitive Landscape
Major companies operating in the artificial intelligence in life sciences market are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Augmedix, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Insitro, Sense.ly Inc., Subtle Medical Inc., Medasense Biometrics Limited, Immunai, Atomwise Inc., Freenome Holdings Inc., CloudMedX Inc.
View The Full Artificial Intelligence In Life Sciences Market Report:
Artificial Intelligence In Life Sciences Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the Artificial Intelligence In Life Sciences market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
